Are you suffering from anxiety and stress associated with cancer? If so, you may be eligible to participate in a study to evaluate the effects of psilocybin on anxiety and distress in patients with cancer.
Volunteers will experience two study drug sessions. Questionnaires and interviews will be used to evaluate multiple outcome variables including the effects of the study drug on mood, quality of life, pain perception and attitude toward illness. This is an FDA and DEA approved study.
For more information and details regarding this study, please contact us.